Inactive Instrument
DIAL BIORFD Stock Nasdaq Stockholm
Stocks
DIABIO BTA
SE0019173832
Biotechnology & Medical Research
| 1 day | +2.99% |
| Manager | Title | Age | Since |
|---|---|---|---|
Karin Wehlin
CEO | Chief Executive Officer | - | 2023-11-22 |
Fata Mrsic
DFI | Director of Finance/CFO | - | 2024-06-13 |
Emelie Danefur
CTO | Chief Tech/Sci/R&D Officer | - | 2023-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 41 | 2020-12-31 | |
| Chairman | 70 | 2020-12-31 | |
Kushagr Punyani
BRD | Director/Board Member | 35 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.99% | +15.00% | - | - | 705K | |
| -2.59% | -5.70% | +50.69% | +86.86% | 70.61B | |
| +3.23% | -10.67% | +6.27% | +53.70% | 51.01B | |
| +1.56% | +1.17% | +8.49% | +31.81% | 48.1B | |
| +0.39% | +0.65% | +31.14% | +28.97% | 42.78B | |
| +0.87% | -8.17% | +293.37% | +642.41% | 40.67B | |
| +1.24% | -1.01% | +10.74% | +100.64% | 40.3B | |
| -2.13% | -1.64% | +8.63% | +46.88% | 30.59B | |
| -0.46% | -1.28% | +42.23% | +20.34% | 28.16B | |
| +5.32% | +0.06% | -5.00% | -12.78% | 24.36B | |
| Average | +1.04% | -2.66% | +49.62% | +110.98% | 41.84B | |
| Weighted average by Cap. | +0.56% | -2.94% | +51.35% | +115.57% |
Employees
4
